Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Factor IX/administration & dosage/therapeutic use"'
Publikováno v:
Haemophilia, Vol. 16 Suppl 5 (2010) pp. 189-193
SUMMARY: The rationale for long-term prophylaxis in more severe forms of von Willebrand's disease (VWD) is obvious, as mucosal bleeding and haemophilia-like joint bleeds resulting in chronic morbidity may occur. However, the experience with prophylac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::22487ae51c7221fdc725574e9b33811d
https://archive-ouverte.unige.ch/unige:20775
https://archive-ouverte.unige.ch/unige:20775
